Bisphenol AF promotes inflammation in human white adipocytes

Area of Science:

• Endocrinology
• Metabolic disease research
• Toxicology

Background:

• Endocrine-disrupting chemicals (EDCs) are linked to obesity.
• Bisphenol AF (BPAF) is a common alternative to Bisphenol A (BPA) in plastics.
• Health risks of BPAF exposure are not well understood.

Purpose of the Study:

• Investigate the effects of BPAF on human adipocyte metabolic function.
• Determine if BPAF interferes with inflammatory signaling pathways.
• Assess BPAF's impact on mitochondrial health.

Main Methods:

• Differentiated human adipocytes and treated with BPAF.
• Analyzed gene and protein expression (STAT1, inflammatory markers).
• Performed microscopy and respirometry to assess mitochondrial function.
• Exposed BPAF-treated adipocytes to interferon-gamma (IFNγ).

Main Results:

• BPAF exposure accelerated adipocyte differentiation but did not affect mature cell markers.
• BPAF treatment failed to suppress the proinflammatory transcription factor STAT1.
• BPAF impaired mitochondrial structure and function.
• BPAF enhanced IFNγ-induced STAT1 activation, disrupting lipid and carbohydrate metabolism.

Conclusions:

• BPAF disrupts human adipocyte metabolic activity by activating inflammatory pathways.
• BPAF compromises mitochondrial health, exacerbating metabolic dysfunction.
• These findings link BPAF exposure to obesity-related metabolic changes.